{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T22:06:19Z","timestamp":1767909979604,"version":"3.49.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1053\/j.ajkd.2017.04.020","type":"journal-article","created":{"date-parts":[[2017,6,7]],"date-time":"2017-06-07T21:30:42Z","timestamp":1496871042000},"page":"368-376","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Cost-effectiveness Analysis of Vascular Access Referral Policies\u00a0in CKD"],"prefix":"10.1053","volume":"70","author":[{"given":"Steven M.","family":"Shechter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Talon","family":"Chandler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Reza","family":"Skandari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadia","family":"Zalunardo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"suppl 1","key":"10.1053\/j.ajkd.2017.04.020_bib1","first-page":"S176","article-title":"Clinical practice guidelines for vascular access","volume":"48","year":"2006","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"10.1053\/j.ajkd.2017.04.020_bib2","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1046\/j.1523-1755.2001.00947.x","article-title":"Type of vascular access and mortality in U.S. hemodialysis patients","volume":"60","author":"Dhingra","year":"2001","journal-title":"Kidney Int"},{"issue":"6","key":"10.1053\/j.ajkd.2017.04.020_bib3","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1681\/ASN.2010111155","article-title":"Hemodialysis vascular access modifies the association between dialysis modality and survival","volume":"22","author":"Perl","year":"2011","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"6","key":"10.1053\/j.ajkd.2017.04.020_bib4","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1111\/j.1523-1755.2005.00752.x","article-title":"Health-related quality of life and estimates of utility in chronic kidney disease","volume":"68","author":"Gorodetskaya","year":"2005","journal-title":"Kidney Int"},{"issue":"4","key":"10.1053\/j.ajkd.2017.04.020_bib5","doi-asserted-by":"crossref","first-page":"708","DOI":"10.2215\/CJN.00170107","article-title":"Association of initial hemodialysis vascular access with patient-reported health status and quality of life","volume":"2","author":"Wasse","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"10.1053\/j.ajkd.2017.04.020_bib6","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s11136-006-9143-7","article-title":"Factors associated with health-related quality of life among hemodialysis patients in the DOPPS","volume":"16","author":"Lopes","year":"2007","journal-title":"Qual Life Res"},{"issue":"10","key":"10.1053\/j.ajkd.2017.04.020_bib7","doi-asserted-by":"crossref","first-page":"3756","DOI":"10.1093\/ndt\/gfs415","article-title":"Con: on cardiovascular outcomes and the arteriovenous fistula: lesser of evils","volume":"27","author":"Amerling","year":"2012","journal-title":"Nephrol Dial Transplant"},{"issue":"10","key":"10.1053\/j.ajkd.2017.04.020_bib8","doi-asserted-by":"crossref","first-page":"3752","DOI":"10.1093\/ndt\/gfs085","article-title":"Pro: the arteriovenous fistula is a blessing of god","volume":"27","author":"Basile","year":"2012","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"10.1053\/j.ajkd.2017.04.020_bib9","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/j.1525-139X.2010.00783.x","article-title":"Whether and when to refer patients for predialysis AVF fistula creation: complex decision making in the face of uncertainty","volume":"23","author":"O'Hare","year":"2010","journal-title":"Semin Dial"},{"issue":"5","key":"10.1053\/j.ajkd.2017.04.020_bib10","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.ajkd.2003.07.003","article-title":"Predictors of successful arteriovenous fistula maturation","volume":"42","author":"Feldman","year":"2003","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1053\/j.ajkd.2017.04.020_bib11","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1046\/j.1523-1755.2003.00724.x","article-title":"Creation, cannulation and survival of arteriovenous fistulae: data from the Dialysis Outcomes and Practice Patterns Study","volume":"63","author":"Rayner","year":"2003","journal-title":"Kidney Int"},{"issue":"16","key":"10.1053\/j.ajkd.2017.04.020_bib12","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1056\/NEJMoa0904655","article-title":"Functional status of elderly adults before and after initiation of dialysis","volume":"361","author":"Tamura","year":"2009","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1053\/j.ajkd.2017.04.020_bib13","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.2215\/CJN.05830710","article-title":"Reevaluating the fistula first initiative in octogenarians on hemodialysis","volume":"6","author":"Vachharajani","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"10.1053\/j.ajkd.2017.04.020_bib14","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/ki.2011.384","article-title":"Optimizing renal replacement therapy in older adults: a framework for making individualized decisions","volume":"82","author":"Tamura","year":"2011","journal-title":"Kidney Int"},{"issue":"10","key":"10.1053\/j.ajkd.2017.04.020_bib15","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1681\/ASN.2012121234","article-title":"Temporal risk profile for infectious and noninfectious complications of hemodialysis access","volume":"24","author":"Ravani","year":"2013","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"6","key":"10.1053\/j.ajkd.2017.04.020_bib16","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1111\/sdi.12037","article-title":"Optimal hemodialysis vascular access in the elderly patient","volume":"25","author":"Moist","year":"2012","journal-title":"Semin Dial"},{"issue":"2","key":"10.1053\/j.ajkd.2017.04.020_bib17","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/sdi.12465","article-title":"A\u00a0patient-centered approach to hemodialysis vascular access in the era of fistula first","volume":"29","author":"Kalloo","year":"2016","journal-title":"Semin Dial"},{"issue":"5","key":"10.1053\/j.ajkd.2017.04.020_bib18","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1111\/sdi.12481","article-title":"Looking beyond \u201cFistula First\u201d in the elderly on hemodialysis","volume":"29","author":"Murea","year":"2016","journal-title":"Semin Dial"},{"issue":"suppl 1","key":"10.1053\/j.ajkd.2017.04.020_bib19","first-page":"S137","article-title":"K\/DOQI clinical practice guidelines for vascular access: update 2000","volume":"37","year":"2000","journal-title":"Am J Kidney Dis"},{"issue":"suppl 2","key":"10.1053\/j.ajkd.2017.04.020_bib20","first-page":"S1","article-title":"K\/DOQI clinical practice guidelines for chronic kidney disease, classification and stratification","volume":"39","year":"2002","journal-title":"Am J Kidney Dis"},{"issue":"3 suppl 1","key":"10.1053\/j.ajkd.2017.04.020_bib21","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1681\/01.asn.0000926804.41981.99","article-title":"Hemodialysis clinical practice guidelines for the Canadian Society of Nephrology: vascular access","volume":"17","author":"Jindal","year":"2006","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"12","key":"10.1053\/j.ajkd.2017.04.020_bib22","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.2215\/CJN.03210410","article-title":"Choice of vascular access among incident hemodialysis patients: a decision and cost-utility analysis","volume":"5","author":"Xue","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"10.1053\/j.ajkd.2017.04.020_bib23","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1053\/j.ajkd.2013.06.021","article-title":"Timing of arteriovenous fistula creation in patients with CKD: a decision analysis","volume":"63","author":"Shechter","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ajkd.2017.04.020_bib24","series-title":"Cost-effectiveness in Health and Medicine","author":"Gold","year":"1996"},{"issue":"2","key":"10.1053\/j.ajkd.2017.04.020_bib25","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jval.2013.02.002","article-title":"Consolidated health economic evaluation reporting standards (CHEERS)\u2013explanation and elaboration: a report of the ISPOR health economic evaluation publication guidelines good reporting practices task force","volume":"16","author":"Husereau","year":"2013","journal-title":"Value Health"},{"issue":"7","key":"10.1053\/j.ajkd.2017.04.020_bib26","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1056\/NEJMoa1000552","article-title":"A\u00a0randomized, controlled trial of early versus late initiation of dialysis","volume":"363","author":"Cooper","year":"2010","journal-title":"N\u00a0Engl J Med"},{"issue":"18","key":"10.1053\/j.ajkd.2017.04.020_bib27","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1001\/jama.299.18.2164","article-title":"Effect of clopidogrel on early failure of arteriovenous fistulas for hemodialysis","volume":"299","author":"Dember","year":"2008","journal-title":"JAMA"},{"issue":"11","key":"10.1053\/j.ajkd.2017.04.020_bib28","doi-asserted-by":"crossref","first-page":"981","DOI":"10.2165\/11599390-000000000-00000","article-title":"Cost-effectiveness analysis of therapies for chronic kidney disease patients on dialysis","volume":"30","author":"Grima","year":"2012","journal-title":"Pharmacoeconomics"},{"issue":"1","key":"10.1053\/j.ajkd.2017.04.020_bib29","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0167-6296(96)00507-3","article-title":"Accounting for future costs in medical cost-effectiveness analysis","volume":"16","author":"Meltzer","year":"1997","journal-title":"J\u00a0Health Econ"},{"key":"10.1053\/j.ajkd.2017.04.020_bib30","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1002\/hec.635","article-title":"Representing uncertainty: the role of cost-effectiveness acceptability curves","volume":"10","author":"Fenwick","year":"2001","journal-title":"Health Econ"},{"issue":"suppl","key":"10.1053\/j.ajkd.2017.04.020_bib31","doi-asserted-by":"crossref","first-page":"S68","DOI":"10.1177\/0272989X98018002S09","article-title":"Net health benefits: a new framework for the analysis of uncertainty in cost-effectiveness analysis","volume":"18","author":"Stinnett","year":"1998","journal-title":"Med Decis Making"},{"issue":"4","key":"10.1053\/j.ajkd.2017.04.020_bib32","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1177\/027298902400448867","article-title":"Probabilistic analysis of cost-effectiveness models: choosing between treatment strategies for gastroesophageal reflux disease","volume":"22","author":"Briggs","year":"2002","journal-title":"Med Decis Making"},{"issue":"1","key":"10.1053\/j.ajkd.2017.04.020_bib33","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/j.1524-4733.2008.00401.x","article-title":"An empiric estimate of the value of life: updating the renal dialysis cost-effectiveness standard","volume":"12","author":"Lee","year":"2009","journal-title":"Value Health"},{"issue":"1","key":"10.1053\/j.ajkd.2017.04.020_bib34","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ejvs.2012.10.012","article-title":"Cost-effectiveness of vascular access for haemodialysis: arteriovenous fistulas versus arteriovenous grafts","volume":"45","author":"Leermakers","year":"2013","journal-title":"Eur J Vasc Endovasc"},{"issue":"1","key":"10.1053\/j.ajkd.2017.04.020_bib35","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1681\/ASN.2013111236","article-title":"Vascular access choice in incident hemodialysis patients: a decision analysis","volume":"26","author":"Drew","year":"2014","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"9","key":"10.1053\/j.ajkd.2017.04.020_bib36","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1056\/NEJMp1405158","article-title":"Updating cost-effectiveness - the curious resilience of the $50,000-per-QALY threshold","volume":"371","author":"Neumann","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1053\/j.ajkd.2017.04.020_bib37","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/MLR.0b013e31815c31a7","article-title":"What does the value of modern medicine say about the $50,000 per quality-adjusted life-year decision rule?","volume":"46","author":"Braithwaite","year":"2008","journal-title":"Med Care"},{"issue":"2","key":"10.1053\/j.ajkd.2017.04.020_bib38","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1681\/ASN.2016010019","article-title":"The survival benefit of \u201cfistula first, catheter last\u201d in hemodialysis is primarily due to patient factors","volume":"28","author":"Brown","year":"2017","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"2","key":"10.1053\/j.ajkd.2017.04.020_bib39","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1681\/ASN.2016020151","article-title":"The effect of predialysis fistula attempt on risk of all-cause and access-related death","volume":"28","author":"Quinn","year":"2017","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"1","key":"10.1053\/j.ajkd.2017.04.020_bib40","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1523-1755.2005.00414.x","article-title":"Septicemia, access and cardiovascular disease in dialysis patients: the USRDS Wave 2 Study","volume":"68","author":"Ishani","year":"2005","journal-title":"Kidney Int"},{"issue":"9","key":"10.1053\/j.ajkd.2017.04.020_bib41","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1097\/01.mlr.0000135812.52570.42","article-title":"Mapping the SF-12 to the HUI3 and VAS in a managed care population","volume":"42","author":"Sengupta","year":"2004","journal-title":"Med Care"},{"issue":"3","key":"10.1053\/j.ajkd.2017.04.020_bib42","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1053\/ajkd.2002.34924","article-title":"Cost analysis of ongoing care of patients with end-stage renal disease: the impact of dialysis modality and dialysis access","volume":"40","author":"Lee","year":"2002","journal-title":"Am J Kidney Dis"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638617307023?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638617307023?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T02:59:42Z","timestamp":1759460382000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638617307023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["S0272638617307023"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2017.04.020","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cost-effectiveness Analysis of Vascular Access Referral Policies\u00a0in CKD","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2017.04.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 by the National Kidney Foundation, Inc.","name":"copyright","label":"Copyright"}]}}